Of note, previous studies have shown that inhibiting NLRP3 inflammasome activation is an effective means to alleviate the damage associated with ischemic stroke and retinal ischemia (Hong et al., 2018; Gong et al., 2019). This evidence concerns the gene NLRP3 and ischemic stroke.